Stereotaxis Inc (STXS)

$2.60 +0.05 (1.96%)
Market Cap 216.51M
Revenue (ttm) 26.92M
Net Income (ttm) -24.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.34%
Debt to Equity Ratio 0.00
Volume 829,400
Avg Vol 596,422
Day's Range N/A - N/A
Shares Out 93.33M
Stochastic %K 68%
Beta 1.44
Analysts Strong Sell
Price Target $4.20

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is design...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 314 678 6100
Address:
710 North Tucker Boulevard, Suite 110, Saint Louis, United States
Dr_Robot
Dr_Robot Jan. 7 at 9:59 PM
$STXS I have stated this is coming; somehow, J&J were aware of this approval for magic as well since they stopped selling the catheters that Genesis was using prior to this announcement. The magic catheter is the glue between the ecosystem of all of stereotaxis products instead of buying catheters at a cost now they make them themselves. It’s an incredible revenue stream since they are disposable one time use.
1 · Reply
trigger_finger
trigger_finger Jan. 7 at 9:30 PM
$STXS FYI.... comparison of the former catheter vs New one. Alex will likely take this info as his own. One important note, the doctor can still do VT surgery, but they risk being liable if something goes wrong. I do expect the VT to gain indication at some point. Would love to know why they didn't gain indication on that.
0 · Reply
alexpitti
alexpitti Jan. 7 at 5:51 PM
for those playing at home $STXS needs ce mark for magic sweep, synchrony fda approval, ce and fda approval for guidecatheter, they need to FINALLY submit the guidewire to regulators, and they need to do the human trial for the PFA catheter (hopefully ce mark in 12 months)
1 · Reply
cheating_stock_investor
cheating_stock_investor Jan. 7 at 5:05 PM
$STXS people dont get the magic catheter approval is the game changer here from dead sales growth to potential. Now we just have to watch how they scale. I was waiting for $AFIB to get the same kind of approval and it was an uphill battle. The previous ceo projected a huge tam for ablation cath sales especially if the results were suprior to the existing ones available to ep's.
1 · Reply
Playthegame06
Playthegame06 Jan. 7 at 8:15 AM
$STXS MAGIC is approved......Is this the beginning of Genesis X purchase orders?
1 · Reply
TonySoprano1987
TonySoprano1987 Jan. 7 at 6:49 AM
$STXS so biggest news / catalyst since forever and this makes a 8% move. Amazing.
0 · Reply
Stonksman16
Stonksman16 Jan. 6 at 8:06 PM
$STXS can we hit 3 before earnings
0 · Reply
S144
S144 Jan. 6 at 7:19 PM
$STXS just secured a $12.5M registered direct offering led by a strategic partner to accelerate product commercialization and strengthen its balance sheet in this milestone-rich year for surgical robotics innovation. @alexpitti
1 · Reply
wallstpirate
wallstpirate Jan. 6 at 6:29 PM
$STXS Someone just posted just secured a $12.5M registered direct offering led by a strategic partner to accelerate product commercialization and strengthen its balance sheet in this milestone-rich year for surgical robotics innovation. https://x.com/jmdejean/status/2008537503809339592
1 · Reply
trigger_finger
trigger_finger Jan. 6 at 6:02 PM
$STXS Price action makes me wonder if David has been discussing some capital raises. They need sales staff asap. 2 million shares on this and its up 14 cents. It didn't go high enough for people to be selling the news.
0 · Reply
Latest News on STXS
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 1 day ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 8:58 AM EST - 6 weeks ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 7:51 PM EST - 2 months ago

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 11, 2025, 4:01 PM EST - 2 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Nov 10, 2025, 4:05 PM EST - 2 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 21, 2025, 9:00 AM EDT - 2 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 15, 2025, 7:32 AM EDT - 3 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Oct 13, 2025, 7:34 AM EDT - 3 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 22, 2025, 7:56 AM EDT - 3 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 8:08 AM EDT - 4 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Stereotaxis to Present at Upcoming Investor Conferences

Sep 2, 2025, 7:51 AM EDT - 4 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 28, 2025, 7:47 AM EDT - 4 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:24 PM EDT - 5 months ago

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Stereotaxis Reports 2025 Second Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 5 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 28, 2025, 7:48 AM EDT - 5 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 23, 2025, 8:00 AM EDT - 6 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 17, 2025, 8:32 AM EDT - 6 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Stereotaxis: Recurring Revenue Inflection

Jul 6, 2025, 2:13 AM EDT - 6 months ago

Stereotaxis: Recurring Revenue Inflection

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Jul 1, 2025, 9:00 AM EDT - 6 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 7:04 PM EDT - 8 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025, 4:01 PM EDT - 8 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 22, 2025, 7:00 AM EDT - 9 months ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 21, 2025, 8:00 AM EDT - 9 months ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 19, 2025, 8:01 AM EDT - 10 months ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Stereotaxis to Present at 37th Annual Roth Conference

Mar 10, 2025, 8:02 AM EDT - 10 months ago

Stereotaxis to Present at 37th Annual Roth Conference

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 7, 2025, 9:10 AM EST - 10 months ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 10:34 AM EST - 11 months ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:32 AM EST - 11 months ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:31 AM EST - 11 months ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Stereotaxis Reports 2024 Full Year Financial Results

Mar 3, 2025, 7:30 AM EST - 11 months ago

Stereotaxis Reports 2024 Full Year Financial Results

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 25, 2025, 8:03 AM EST - 11 months ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 14, 2025, 10:41 AM EST - 11 months ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Stereotaxis Announces First GenesisX Robotic System Order

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Dec 2, 2024, 5:03 AM EST - 1 year ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 7:03 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Third Quarter Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Sep 3, 2024, 8:53 AM EDT - 1 year ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Aug 25, 2024, 7:22 PM EDT - 1 year ago

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:33 PM EDT - 1 year ago

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Aug 12, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Dr_Robot
Dr_Robot Jan. 7 at 9:59 PM
$STXS I have stated this is coming; somehow, J&J were aware of this approval for magic as well since they stopped selling the catheters that Genesis was using prior to this announcement. The magic catheter is the glue between the ecosystem of all of stereotaxis products instead of buying catheters at a cost now they make them themselves. It’s an incredible revenue stream since they are disposable one time use.
1 · Reply
trigger_finger
trigger_finger Jan. 7 at 9:30 PM
$STXS FYI.... comparison of the former catheter vs New one. Alex will likely take this info as his own. One important note, the doctor can still do VT surgery, but they risk being liable if something goes wrong. I do expect the VT to gain indication at some point. Would love to know why they didn't gain indication on that.
0 · Reply
alexpitti
alexpitti Jan. 7 at 5:51 PM
for those playing at home $STXS needs ce mark for magic sweep, synchrony fda approval, ce and fda approval for guidecatheter, they need to FINALLY submit the guidewire to regulators, and they need to do the human trial for the PFA catheter (hopefully ce mark in 12 months)
1 · Reply
cheating_stock_investor
cheating_stock_investor Jan. 7 at 5:05 PM
$STXS people dont get the magic catheter approval is the game changer here from dead sales growth to potential. Now we just have to watch how they scale. I was waiting for $AFIB to get the same kind of approval and it was an uphill battle. The previous ceo projected a huge tam for ablation cath sales especially if the results were suprior to the existing ones available to ep's.
1 · Reply
Playthegame06
Playthegame06 Jan. 7 at 8:15 AM
$STXS MAGIC is approved......Is this the beginning of Genesis X purchase orders?
1 · Reply
TonySoprano1987
TonySoprano1987 Jan. 7 at 6:49 AM
$STXS so biggest news / catalyst since forever and this makes a 8% move. Amazing.
0 · Reply
Stonksman16
Stonksman16 Jan. 6 at 8:06 PM
$STXS can we hit 3 before earnings
0 · Reply
S144
S144 Jan. 6 at 7:19 PM
$STXS just secured a $12.5M registered direct offering led by a strategic partner to accelerate product commercialization and strengthen its balance sheet in this milestone-rich year for surgical robotics innovation. @alexpitti
1 · Reply
wallstpirate
wallstpirate Jan. 6 at 6:29 PM
$STXS Someone just posted just secured a $12.5M registered direct offering led by a strategic partner to accelerate product commercialization and strengthen its balance sheet in this milestone-rich year for surgical robotics innovation. https://x.com/jmdejean/status/2008537503809339592
1 · Reply
trigger_finger
trigger_finger Jan. 6 at 6:02 PM
$STXS Price action makes me wonder if David has been discussing some capital raises. They need sales staff asap. 2 million shares on this and its up 14 cents. It didn't go high enough for people to be selling the news.
0 · Reply
alexpitti
alexpitti Jan. 6 at 5:40 PM
$STXS fda approval of magic. I waited 5 years for this.
2 · Reply
_Not_Sure_
_Not_Sure_ Jan. 6 at 5:19 PM
$STXS I find the price action odd here.
1 · Reply
notreload_ai
notreload_ai Jan. 6 at 5:08 PM
$STXS receives FDA approval for MAGiC catheter, a magnetically-guided robotic device for treating complex heart rhythm disorders in hard-to-reach patients. https://notreload.xyz/stereotaxis-gets-fda-green-light-for-robot-controlled-heart-catheter/
0 · Reply
elinadavid36
elinadavid36 Jan. 6 at 4:25 PM
$STXS SI ~10.66% + DTC ~1.7 isn’t a squeeze thesis… but it’s enough spice when volume hits. Add growth receipts and it can get spicy fast 🚀 company name in bio
0 · Reply
S144
S144 Jan. 6 at 4:05 PM
$STXS Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained U.S. Food and Drug Administration (FDA) approval for the MAGiC™ Magnetic Interventional Ablation Catheter. https://seekingalpha.com/pr/20354197-stereotaxis-receives-fda-approval-for-magic-ablation-catheter
0 · Reply
RemitTekram
RemitTekram Jan. 6 at 3:24 PM
$STXS Glad I got more cheapies when they were available. LFG
1 · Reply
Eddypgil
Eddypgil Jan. 6 at 3:10 PM
$STXS I’d still buy at $2.66
1 · Reply
TheInvOb
TheInvOb Jan. 6 at 2:38 PM
$STXS Watching the order book and the virtual lack of volume at in the first few minutes given the news, this feels like it caught the market makers 100% off-guard. It's going to be interesting to see how the order book flows throughout the day. Surely there will be a profit taking wave (at least in my opinion), the question is what will be the intraday low? Any guesses? Mid $2.50S? And of course as I finish typing this, the price has jumped from $2.66 to $2.74 so it's going to be very interesting to watch this today.
1 · Reply
Eddypgil
Eddypgil Jan. 6 at 2:29 PM
$STXS any shorts are covering. $3 + today
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 1:57 PM
$STXS 08:47 on Jan. 06 2026 Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter #tradeideas
0 · Reply
trigger_finger
trigger_finger Jan. 6 at 1:55 PM
$STXS Big day for Stereotaxis, they now officially have a business model to grow. While its unfortunate it took this long, and Magic won't have the sales it should have for 2026, 2027 and beyond should be a lot more optimistic Should be a celebration day for all that own this as an investment. The floor should be in now.
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 1:53 PM
$STXS 08:13 on Jan. 06 2026 Stereotaxis Receives FDA Approval For MAGiC Magnetic Interventional Ablation Catheter For Robotic Cardiac Ablation In Complex Congenital Heart Disease Patients #tradeideas
0 · Reply